Call: +1 (800) 752-8538

EqPA & Pall Corporation sponsor Wet Lab

Equine Partners America, LLC and Pall Corporation sponsored a Wet Lab for CE credit at The Kentucky Equine Veterinary Spring Seminar on Thursday, April 26, 2012, at Lexington Equine Surgery and Sports Medicine, just one mile from the Kentucky Horse Park in Lexington, KY; and on Friday, April 27, 2012, at the Kentucky Horse Park in Lexington, KY, during the Rolex Kentucky Three-Day Event.

This seminar has been endorsed by the Kentucky Association of Equine Practitioners (15 CE hours credit). The focus of the seminar was on back and pelvic limb lameness, and included new technologies and research on the subject.

Equine Partners America, LLC and Pall Corporation hosted a lab entitled, "Protocols and Practical Experience in Aspiration Using The VetCell Stem Cell Procedure and E-PET™ Product Administration" on Thursday morning, April 26, 2012.

This four-hour wet lab began with a talk about the VetCell protocol history and technology, then moved on to practical application with the use of ultrasound on live horses to guide participants through the learning experience of aspirating bone marrow via the sternum. Participants were then provided the opportunity to practice this technique on their own with help from the lecturer of this session, Dr. Jimmy C. Nash.

Dr. Nash is the owner of Horner & Nash, DVM, PC, which is a four-veterinarian practice offering excellence in equine medicine, basic surgery, lameness, preventative medicine, reproduction, dentistry, nutrition and 24/7 emergency equine emergency care in the north Atlanta area.

The second half of the session was spent on administering the E-PET™ platelet product from Pall Corporation. This innovative product is completely stall-side and does not require the use of a centrifuge to get 7x platelet enhanced therapy.

This portion of the wet lab was conducted by Dr. Jeffrey Schaffer, Director Pall Life Science - Animal Health for New Initiative in Regenerative Medicine, Cell Therapy regarding Stem Cells, PRP and Prion Products, for PALL Life Sciences, Pall Corporation, East Hills, NY.

2012-01-16

EqPA Participating in new Trials/Studies


Dr. Roger K Smith

2012 will be an exciting year for Equine Partners America, as we are working with our partners on getting several studies and trials off the ground.

The most important trial we are starting is on RenovoCyte's new stem cell protocol for tendon and ligament injuries. It will be using a unique and non-invasive collection method for stem cells using skin. We are looking for candidates for this trial and to get us started, the pricing is extremely attractive for the first 6 to 10 horses. So if you have a need and want to be part of a great new offering, please call us at 1-800-752-8538 to get the details on the protocol.

A Bleeders Study has already begun with RenovoCyte, and again, we are still looking for candidates for this study. We have had great results thus far. We would be happy to discuss the stem cell protocol that will be used in the study so again, if you have any candidates, please let us know. We will also begin a Laminitis Study with RenovoCyte, again using RenovoCyte's large dose stem cell protocol.

Finally, we continue to accept applicants for the trial involving platelet-rich plasma (PRP) and stem-cell treatment, which utilize Pall's Veterinarian Platelet Enhanced Therapy (E-PET) and VetCell stem cell protocol. This trial is dedicated to addressing soft-tissue injuries sustained in various disciplines, specifically to ligaments and tendons common in the equine athlete.

Drs. Scott Swerdlin, Jeffrey Schaffer, R.K. Smith, and M. McCracken, Equine Partners Foremost stem cell authority Dr. Roger Smith participates in educational seminar hosted by Palm Beach Equine Clinic

We'd like to thank everybody for the wonderful turnout we enjoyed in Wellington on January 16, when Dr. Roger Smith spoke on "A Biological Approach to treating Tendon and Ligament Injuries". We'd like to thank Drs. Smith and Schaffer for their time and informative insights, as well as the entire staff of the Palm Beach Equine Clinic for their generous efforts. With over 30 equine practitioners attending the event, the feedback we have gotten has been tremendous.

Dr. Nash is the owner of Horner & Nash, DVM, PC, which is a four-veterinarian practice offering excellence in equine medicine, basic surgery, lameness, preventative medicine, reproduction, dentistry, nutrition and 24/7 emergency equine emergency care in the north Atlanta area.

The second half of the session was spent on administering the E-PET™ platelet product from Pall Corporation. This innovative product is completely stall-side and does not require the use of a centrifuge to get 7x platelet enhanced therapy.

This portion of the wet lab was conducted by Dr. Jeffrey Schaffer, Director Pall Life Science - Animal Health for New Initiative in Regenerative Medicine, Cell Therapy regarding Stem Cells, PRP and Prion Products, for PALL Life Sciences, Pall Corporation, East Hills, NY.

2012-01-10

Foremost stem cell authority Dr. Roger Smith to participate in educational seminar hosted by Palm Beach Equine Clinic

DAWSONVILLE, Ga. - Dr. Roger K. W. Smith, one of the world's leading authorities on stem cell technologies and their use in treating soft-tissue injuries, will be the keynote speaker of an educational seminar hosted by the Palm Beach Equine Clinic on January 16.

Dr. Smith is currently the Professor of Equine Orthopedics at the Royal Veterinary College in London, England. During the seminar he will spearhead discussion on specific innovations that have emerged to treat leg injuries in performance horses around the world. Entitled "A Biological Approach to Treating Tendon and Ligament Injuries," Dr. Smith's presentation will also detail emerging veterinary technologies that are being used to rehabilitate injured sport horses in all disciplines. Topics will include the epidemiology of tendon disease in the horse, the development of serological assay for tendonitis, and stem cell and platelet therapies for treating compromised tendons and ligaments.

Dr. Smith currently runs a specialist orthopedic service within the Royal Veterinary College. Through this service he directs a broad range of research projects into equine tendon disease. His primary area of research concentrates on the mechanisms of tendon aging, which extends to stem cell therapies developed in conjunction with a commercial endeavor, VetCell, he helped found.

The event is being sponsored by Equine Partners America, LLC, which was founded to supply products from the regenerative medical field to equine practitioners throughout North America. Equine Partners America focuses on veterinary products to help rehabilitate performance horses using VetCell and RenovoCyte Stem Cell Therapies and Veterinarian Platelet Enhancement Therapy (E-Pet) from Pall Corporation.

"We are quite pleased and excited to welcome Dr. Roger Smith to this educational event," said Moira McCracken, director of veterinary sales for Equine Partners America. "Dr. Smith is one of the world's foremost authorities in his field, and his expertise and insights into tendon injuries and stem cell treatments will be invaluable to everyone in attendance.

Dr. Jeffrey A. Schaffer, Director of Pall Life Science-Animal Health for New Initiative in Regenerative Medicine, will also be a featured speaker during this one-night event. The event will be conducted at the White Horse Tavern in Wellington, Florida. It will commence at 6:30 pm and include dinner and a cocktail reception.

Dr. Nash is the owner of Horner & Nash, DVM, PC, which is a four-veterinarian practice offering excellence in equine medicine, basic surgery, lameness, preventative medicine, reproduction, dentistry, nutrition and 24/7 emergency equine emergency care in the north Atlanta area.

The second half of the session was spent on administering the E-PET™ platelet product from Pall Corporation. This innovative product is completely stall-side and does not require the use of a centrifuge to get 7x platelet enhanced therapy.

This portion of the wet lab was conducted by Dr. Jeffrey Schaffer, Director Pall Life Science - Animal Health for New Initiative in Regenerative Medicine, Cell Therapy regarding Stem Cells, PRP and Prion Products, for PALL Life Sciences, Pall Corporation, East Hills, NY.

Pullquotes

Sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat enim ad minim veniam.

Adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipi- sicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit.

Lorem ipsum dolor sit amet, consectetur adipi- sicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit.

design by GrafX by Laurie